FDA
approval
· 2024-06-12
FDA Approved: LANSOPRAZOLE, AMOXICILLIN, CLARITHROMYCIN — Supplemental Application (Rising Pharma Holdings, Inc.)
Summary
FDA approved a supplemental application for the fixed-dose combination of lansoprazole, amoxicillin, and clarithromycin from Rising Pharma Holdings, Inc., for t…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for LANSOPRAZOLE, AMOXICILLIN, CLARITHROMYCIN (LANSOPRAZOLE, AMOXICILLIN, CLARITHROMYCIN)